Carbon Dioxide
In clinical developmentAlso known as CO2 - Carbon dioxide, Carbonic anhydride.
Recent clinical, regulatory, research and industry developments relating to this drug.
The oceans near Australia may be the best places to fertilize for removing carbon dioxide
Global vessel carbon dioxide emission from navigable rivers
Global vessel carbon dioxide emission from navigable rivers
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion
Applied Physiology of Oxygen Toxicity: Mechanisms in Humans
The underpinnings of the BOLD functional magnetic resonance imaging signal.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes7
Journals, researchers & institutions
- Plant, cell & environment1
- Resuscitation1
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Andersen GØ1
- Bellomo R1
- Buti S1
- de Boer HJ1
- Eastwood G1
- Flaa A1
- Huber M1
- Kahlon PS1
- Austin Hospital1
- Copernicus Institute of Sustainable Development1
- Groningen Institute for Evolutionary Life Sciences1
- Laboratory of Molecular Biology1
- Laboratory of Plant Physiology1
- Max Planck Institute for Biological Cybernetics1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials